BSVN vs EW · P/E 9.2, rev $64.7M vs P/E 47, rev $3.39B
Bank7 Corp (BSVN) versus Edwards Lifesciences Corp (EW) — a side-by-side from cached financials, not a winner call.
Bank7 Corp (BSVN) is a banks - regional company listed on US.
Edwards Lifesciences Corp (EW) is a medical devices company listed on NYSE.
Latest reported BSVN revenue for 2026-06-30 was $64.7M. Net income was $20.4M. Revenue was up 91.5% from 2026-03-31 to 2026-06-30. BSVN currently screens at market cap $420.2M and trailing P/E 9.2.
Latest reported EW revenue for 2026-06-30 was $3.39B. Net income was $622.6M. EW currently screens at market cap $49.91B and trailing P/E 46.9.
BSVN currently screens at market cap $420.2M and trailing P/E 9.2. EW currently screens at market cap $49.91B and trailing P/E 46.9.
Not investment advice. Open the BSVN and EW stock pages for the full models.
Not investment advice.